Literature DB >> 19733159

Biological variability of blood omega-3 biomarkers.

William S Harris1, Rachael M Thomas.   

Abstract

OBJECTIVES: We conducted a pilot study to estimate the biological variability and effects of a prior meal on the omega-3 fatty acid (FA) content of 3 blood FA pools. DESIGN AND METHODS: We measured FA levels in red blood cells (RBCs), plasma and plasma phospholipids (PL) obtained from 20 healthy volunteers tested weekly over 6 weeks.
RESULTS: The within-subject coefficients of variation were 4.1%+/-1.9%, 15.9%+/-6.4%, and 14.5%+/-8.4%, respectively (RBC vs. others, p<0.001). RBC omega-3 FA content had the lowest biological variability and was not altered in the fed state.
CONCLUSIONS: From the perspective of variability and of the sample types tested, RBCs may be the preferred sample type for assessing omega-3 FA status. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733159     DOI: 10.1016/j.clinbiochem.2009.08.016

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  53 in total

1.  Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.

Authors:  Melinda S Schaller; Greg J Zahner; Warren J Gasper; William S Harris; Michael S Conte; Nancy K Hills; S Marlene Grenon
Journal:  J Clin Lipidol       Date:  2017-06-24       Impact factor: 4.766

2.  Association between Red Blood Cells Omega-3 Polyunsaturated Fatty Acids and White Matter Hyperintensities: The MAPT Study.

Authors:  S Y Moon; P de Souto Barreto; M Chupin; J F Mangin; A Bouyahia; L Fillon; S Andrieu; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study.

Authors:  James V Pottala; Kristine Yaffe; Jennifer G Robinson; Mark A Espeland; Robert Wallace; William S Harris
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

4.  Omega-3 index levels and associated factors in a middle-aged French population: the MONA LISA-NUT Study.

Authors:  A Wagner; C Simon; B Morio; J Dallongeville; J B Ruidavets; B Haas; B Laillet; D Cottel; J Ferrières; D Arveiler
Journal:  Eur J Clin Nutr       Date:  2014-10-22       Impact factor: 4.016

5.  Peripheral Artery Disease Is Associated with a Deficiency of Erythrocyte Membrane n-3 Polyunsaturated Fatty Acids.

Authors:  Joel L Ramirez; Greg J Zahner; Kimberly A Spaulding; Sukaynah A Khetani; Nancy K Hills; Warren J Gasper; William S Harris; Beth E Cohen; S Marlene Grenon
Journal:  Lipids       Date:  2019-03-18       Impact factor: 1.880

6.  Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging.

Authors:  Z S Tan; W S Harris; A S Beiser; R Au; J J Himali; S Debette; A Pikula; C Decarli; P A Wolf; R S Vasan; S J Robins; S Seshadri
Journal:  Neurology       Date:  2012-02-28       Impact factor: 9.910

7.  RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Authors:  J Thomas Brenna; Graham C Burdge; Michael A Crawford; Paul Clayton; Stephen C Cunnane; Rachel Gow; Joseph R Hibbeln; Andrew J Sinclair; John Stein; Peter Willatts
Journal:  J Natl Cancer Inst       Date:  2014-03-31       Impact factor: 13.506

8.  Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.

Authors:  Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha
Journal:  Lipids       Date:  2017-04-24       Impact factor: 1.880

Review 9.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

10.  RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials.

Authors:  Theodore R Witte; Alexander J Salazar; Oscar F Ballester; W Elaine Hardman
Journal:  Lipids Health Dis       Date:  2010-03-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.